
Vijay Yadava
About Vijay Yadava
Data last updated:
Vijay Yadava is a Director at Vermed Laboratories Private Limited (since 2015). The companies operate in Trading. Vermed Laboratories Private Limited reported revenue of ₹15.1 Lakh (FY 2017). Earlier, Vijay Yadava was a Director at Bluemed Pharma Private Limited (2014).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 11 Feb 2015 | 2015 | ₹15.1 Lakh (FY 2017) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 13 Mar 2014 | 2014 | ₹71.5 Lakh (FY 2017) | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Vijay Yadava
| Name | DIN | Company | Designation |
|---|---|---|---|
| Meera Rani Verma | 07360096 | Vermed Laboratories Private Limited | Director |
| Sadhana Srivastava | 07360080 | Vermed Laboratories Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vijay Yadava
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vijay Yadava
Vijay Yadava currently holds 1 directorship: Vermed Laboratories Private Limited (Director, since 11 Feb 2015, revenue ₹15.1 Lakh (FY 2017)).
Vijay Yadava was first appointed on 13 Mar 2014 as Director at Bluemed Pharma Private Limited. The most recent appointment on record is 11 Feb 2015 at Vermed Laboratories Private Limited.
Vijay Yadava held 1 earlier board appointment: Bluemed Pharma Private Limited (Director, 13 Mar 2014 to 17 Jun 2014).
The current boards of Vijay Yadava's companies include Meera Rani Verma (Vermed Laboratories Private Limited), Sadhana Srivastava (Vermed Laboratories Private Limited).